ROS1-rearranged non-small cell lung carcinoma

From Libre Pathology

Revision as of 02:18, 31 December 2019 by Michael (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

ROS1-rearranged non-small cell lung carcinoma is a subtype of non-small cell lung carcinoma that can be treated with ALK inhibitors.^[1]

General

ROS1-rearrangements are seen in approximately 1-2% of non-small cell carcinoma.^[2]

See also

References

↑ Shaw, AT.; Ou, SH.; Bang, YJ.; Camidge, DR.; Solomon, BJ.; Salgia, R.; Riely, GJ.; Varella-Garcia, M. et al. (Nov 2014). "Crizotinib in ROS1-rearranged non-small-cell lung cancer.". N Engl J Med 371 (21): 1963-71. doi:10.1056/NEJMoa1406766. PMID 25264305.
↑ "Targeted therapies for ROS1-rearranged non-small cell lung cancer". Drugs Today 55 (10): 641–652. October 2019. doi:10.1358/dot.2019.55.10.3030646. PMID 31720561.

Retrieved from "https://librepathology.org/w/index.php?title=ROS1-rearranged_non-small_cell_lung_carcinoma&oldid=50591"

Diagnosis